PetMed Express (PETS) Stock Forecast, Price & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetMed Express in the last year. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" PETS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PETS, but not buy additional shares or sell existing shares.
View PETS analyst ratings or view top-rated stocks.

2 analysts have issued 12-month price objectives for PetMed Express' shares. Their PETS share price forecasts range from $17.00 to $20.00. On average, they predict the company's share price to reach $18.50 in the next twelve months. This suggests a possible upside of 18.2% from the stock's current price.
View analysts price targets for PETS or view top-rated stocks among Wall Street analysts.

PetMed Express' stock was trading at $17.70 at the beginning of 2023. Since then, PETS stock has decreased by 11.6% and is now trading at $15.65.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, July 24th 2023.
View our PETS earnings forecast.

PetMed Express, Inc. (NASDAQ:PETS) announced its quarterly earnings data on Monday, May, 22nd. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of $0.14 by $0.39. The company earned $62.41 million during the quarter, compared to the consensus estimate of $69.93 million. PetMed Express had a net margin of 0.09% and a trailing twelve-month return on equity of 4.90%. During the same quarter last year, the company earned $0.30 earnings per share.

PetMed Express declared a quarterly dividend on Monday, May 22nd. Stockholders of record on Tuesday, June 6th will be paid a dividend of $0.30 per share on Monday, June 12th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 7.67%. The ex-dividend date is Monday, June 5th.
Read our dividend analysis for PETS.

ETFs with the largest weight of PetMed Express (NASDAQ:PETS) stock in their portfolio include Timothy Plan Market Neutral ETF (TPMN), Formidable ETF (FORH), Invesco S&P SmallCap High Dividend Low Volatility ETF (XSHD), Global SuperDividend US ETF (DIV), Amplify Online Retail ETF (IBUY), ProShares Russell 2000 Dividend Growers ETF (SMDV), Roundhill Acquirers Deep Value ETF (DEEP) and RiverFront Dynamic US Dividend Advantage ETF (RFDA).

PetMed Express (NASDAQ:PETS) pays an annual dividend of $1.20 per share and currently has a dividend yield of 8.18%. PETS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 6,003.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, PETS will have a dividend payout ratio of 196.72% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for PETS.

5 employees have rated PetMed Express Chief Executive Officer Mendo Akdag on Glassdoor.com. Mendo Akdag has an approval rating of 46% among the company's employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Verizon Communications (VZ), Netflix (NFLX) and Micron Technology (MU).

PetMed Express trades on the NASDAQ under the ticker symbol "PETS."

PetMed Express' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (16.37%), State Street Corp (4.74%), Renaissance Technologies LLC (4.59%), Mirae Asset Global Investments Co. Ltd. (3.32%), Dimensional Fund Advisors LP (3.15%) and ProShare Advisors LLC (2.65%). Insiders that own company stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Ronald J Korn.
View institutional ownership trends.

Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PETS stock can currently be purchased for approximately $15.65.

PetMed Express (NASDAQ:PETS) has a market capitalization of $331.31 million and generates $256.86 million in revenue each year. The company earns $230,000.00 in net income (profit) each year or $0.02 on an earnings per share basis.

The company employs 219 workers across the globe.

PetMed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The official website for the company is www.1800petmeds.com. The company can be reached via phone at (561) 526-4444, via email at investor@petmeds.com, or via fax at 561-526-4445.